Article
Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program.
American journal of clinical pathology - 3 Mar 2022
Ejegod Ditte Møller, Pedersen Helle, Pedersen Birgitte Tønnes, Jonassen Christine Monceyron, Lie Agnes Kathrine, Hulleberg Laila Solhaug, Arbyn Marc, Bonde Jesper
Abstract excerpt
OBJECTIVES: This study presents the clinical assessment of the Onclarity HPV Assay (Becton Dickinson) on the novel COR high-throughput instrument (Becton Dickinson) using the international guidelines in a routine setting. METHODS: Screening samples collected in BD SurePath from women aged 30 years and older were used in this validation. Noninferiority of the Onclarity HPV Assay on the COR instrument...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.